A liver-targeted tripeptide bioregulator supporting hepatic gene normalisation and regeneration.
A tripeptide (Glu-Asp-Leu) bioregulator from the Khavinson series targeting hepatic tissue. Research proposes it normalises gene expression in hepatocytes by interacting with DNA regulatory elements, reducing oxidative stress markers and supporting liver regenerative capacity.
Used in Russian clinical practice for liver support in elderly patients and those with hepatic stress. Part of comprehensive bioregulator longevity protocols covering multiple organ systems.
The hepatic specificity of Ovagen versus whole-body bioregulators like Epithalon makes it useful in targeted organ support protocols within the Khavinson framework.